Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Extracellular Vesicles 2023: Technologies, Biomarker Cargo & Diagnostics

Extracellular Vesicles 2023: Technologies, Biomarker Cargo & Diagnostics

Conference Chairmen

Michael Graner

Michael Graner
Professor, University of Colorado Anschutz School of Medicine

Mei He

Mei He
Associate Professor, University of Florida

Keynote Speakers

Shilpa Buch
Professor and Senior Executive Vice Chair for Research, University of Nebraska Medical Center

Andrew Godwin
Professor and Division Director, Genomic Diagnostics, Founding Director, Kansas Institute for Precision Medicine, Deputy Director, KU Cancer Center, University of Kansas Medical Center

Fatah Kashanchi
Professor and Director of Research, Lab of Molecular Virology, George Mason University

Kristin Kopperud
Program Director, Biomedicine, International Space Station National Laboratory

Lucia Languino
Professor of Cancer Biology, Thomas Jefferson University

Terry Morgan
Professor, Oregon Health and Science University

Dominique PV de Kleijn
Professor Experimental Vascular Surgery, Professor Netherlands Heart Institute, University Medical Center Utrecht, The Netherlands


SelectBIO is delighted to welcome you to the Extracellular Vesicles 2023 Conference: From Technologies to Biomarker Cargo to Diagnostics.

This conference is being held July 26-27, 2023 in Orlando, Florida close to the Walt Disney World Resort and Attractions.

SelectBIO is honored to welcome Professor Mei He, University of Florida as Conference Chairperson.

This conference brings together academic and industry participants for a 2-day deep dive into timely topics in the Extracellular Vesicles (EVs) field with emphasis on technologies for isolation and study of extracellular vesicles as well as the downstream studies in the EV field such as therapeutics development.

In addition to the biomarker and diagnostic potential of EVs, we explore at this conference the latest work and developments in EV-based Therapeutics and the Drug Delivery and Therapeutics Opportunities in the EV Field.

Presentations at this conference from academics as well as industry participants and the goal is 2-days of scientific exchange as well as networking opportunities.

We welcome exhibitors and companies in the field to engage and participate at this conference and showcase their latest developments and offerings to the field.

**This is a 2-Track Conference with Attendees Accessing All 2-Tracks**
  • One Track Focuses on EV Technologies, Biomarkers & Diagnostics
  • The Other Track Focuses on EV-based Drug Delivery, Biologics and Therapeutics Development

Agenda Topics

  • Biomarker Content of Extracellular Vesicles and Role for Diagnostics Development
    • Proteins and Lipids
    • Small RNAs such as microRNA Cargo within EVs
    • Technologies for Study of EV RNA Cargo such as RNA-Seq
  • Disease Areas where EV-based Diagnostics Being Developed
  • Single Extracellular Vesicle (EV) Analysis by Flow Cytometry
  • Technologies for the Isolation, Characterization and Study of Extracellular Vesicles (EVs)-Exosomes

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager

Distinguished Faculty

Hyungsoon Im, Assistant Professor, Center for Systems Biology, Mass General Hospital (MGH)/Harvard Medical School
Yong Zeng, Associate Professor, Department of Chemistry, University of Florida
Anna Testa, Medical Resident, Thomas Jefferson University; Internal Medicine Fellow, University of Tur
Gerardo Kaplan, Principal Investigator, FDA
Liang Wang, Senior Member of Tumor Biology, Moffitt Cancer Center

Corporate SponsorsWeb SponsorsOffical Journal PartnerNetworking
Drug Discovery WorldU-Networks